E Fund Management (HK)’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
E Fund Management (HK)'s IONS Position: Q3 2026 in Review
E Fund Management (HK) increased its Ionis Pharmaceuticals (IONS) stake by 10% in Q3 2026, buying an estimated $1.53K and bringing the position to 287 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #473.
E Fund Management (HK) first reported a position in IONS in Q1 2026 and has held it in 3 quarters since. The position peaked at $20.6K in Q2 2026. 458 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- E Fund Management (HK) held 287 shares of Ionis Pharmaceuticals worth $12.8K as of Q3 2026.
- E Fund Management (HK) bought 27 Ionis Pharmaceuticals shares in Q3 2026, an estimated $1.53K.
- Ionis Pharmaceuticals made up ﹤0.01% of E Fund Management (HK)'s portfolio in Q3 2026, its #473 holding.
- E Fund Management (HK) first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- E Fund Management (HK)'s Ionis Pharmaceuticals position peaked at $20.6K in Q2 2026.
- 458 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on E Fund Management (HK)'s 13F filing for Q3 2026, filed 12 Nov 2026.